Deep Track Capital, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001856083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 72 positions · Total reported value $5.99B · Top-10 concentration 44.4% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 56.0% · 18 new · 17 cut · 12 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -11.1% · vs SPY -13.3% · Prev Value $6.72B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.0% · vs SPY -4.1% · Latest Value $5.99B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Deep Track Capital, LP disclosed 72 equity positions with a combined reported value of $5.99B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 44.4% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were GH ($500.42M), BMRN ($382.46M), IMVT ($309.45M). By sector, the heaviest allocations are Health Care 98.2%, Technology 1.4%. Versus the prior quarter, allocation shifted toward Health Care (+2.8pp), Technology (+1.4pp) and away from Other (-4.3pp).

Versus the prior quarter, Deep Track Capital, LP opened 18 new positions, trimmed 17 and fully exited 12, a turnover rate of 56.0% of positions. The portfolio's overlap with the prior quarter was 64% of names.

The largest new positions opened in Q3 2026 were INSM ($154.09M), TEM ($81.90M), ARTV ($73.62M).

Of the 12 positions fully exited versus the prior quarter, the largest were ALNY ($248.35M), NUVL ($220.24M), IONS ($174.44M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • INSM INSMED INC · $154.09M
  • TEM TEMPUS AI INC · $81.90M
  • ARTV LATIGO BIOTHERAPEUTICS INC · $73.62M
  • BBIO BRIDGEBIO PHARMA INC · $58.29M
  • ATOS ATTOVIA THERAPEUTICS INC · $54.97M
  • BLLN BILLIONTOONE INC · $53.22M
  • EWTX EDGEWISE THERAPEUTICS INC · $46.64M
  • ANIP ANI PHARMACEUTICALS INC · $36.33M

Fully Exited (vs previous quarter)

  • ALNY ALNYLAM PHARMACEUTICALS INC · prev qtr: $248.35M
  • NUVL NUVALENT INC · prev qtr: $220.24M
  • IONS IONIS PHARMACEUTICALS INC · prev qtr: $174.44M
  • ATAI Ataibeckley Inc CVR · prev qtr: $75.98M
  • CYTK CYTOKINETICS INC · prev qtr: $59.63M
  • PSNL PERSONALIS INC · prev qtr: $53.60M
  • IMMX IMMIX BIOPHARMA INC · prev qtr: $28.61M
  • KURA KURA ONCOLOGY INC · prev qtr: $21.70M

Insider Transactions (Form 4)

Latest Deep Track Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 1,957,138 — SEC filing

All insider transactions →

Fund Profile

Deep Track Capital, LP is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 66 US equity positions with a combined value of $6.72B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-120500 (status: Approved), registered 2021-03-12
  • Regulatory AUM (Form ADV): $8.37B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: deeptrackcapital.com

Portfolio Structure

  • 66 positions · $6.72B reported value (Q2 2026)
  • Top 10 holdings = 40.5% of reported value
  • Largest position: GH (GUARDANT HEALTH INC) at 7.6%
  • Average position size: $101.75M

Sector Tilt

  • Health Care 95.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 18 new, 20 added, 15 reduced, 15 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: Aggressive reallocation into biotech/healthcare names, with a bullish bias on clinical-stage therapeutics (evidenced by sharp increases in BMRN, VERA, UTHR) and selective profit-taking on prior winners (GH, PCVX). 2. Key moves: - Added: BMRN (+3.56% wt, +92.7% shares), UTHR (+1.71% wt, +142.7% shares), VERA (+1.21% wt, +75.0% shares). - Reduced: GH (-0.78% wt, -17.3% shares), PCVX (-0.38% wt, -18.3% shares), IMVT (-0.19% wt, -1.9% shares). 3. Portfolio structure: Highly active, concentrated in healthcare (100% top-10), with high risk appetite (small/mid-cap biotech focus, frequent position sizing changes). 4. Per-holding one-liner: - GH: Guardant Health (liquid biopsy, unverified). - BMRN: BioMarin (enzyme therapies, unverified). - IMVT: Immunovant (autoimmune antibodies, unverified). - TARS: Tarsus (scabies treatment, unverified). - MANE: Veradermics (skin disease, unverified). - VERA: Vera Therapeutics (kidney inflammation, unverified). - PCVX: Vaxcyte (vaccine development, unverified). - ALKS: Alkermes (CNS drugs, unverified). - OCUL: Ocular Therapeutix (eye disease, unverified). - UTHR: United Therapeutics (pulmonary/hypertension, unverified). 5. Style summary: Biotech-focused activist fund rotating into high-conviction clinical-stage names while trimming overexposed positions.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:00

Sector Allocation

Health Care 98.2%
Technology 1.4%
Financials 0.2%
Other 0.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.81M $500.42M 8.36%
8.36%
Reduce
2 6.37M $382.46M 6.38%
6.38%
Add
3 9.16M $309.45M 5.17%
5.17%
Reduce
4 3.81M $299.25M 5.00%
5.00%
Add
5 1.90M $230.34M 3.85%
3.85%
Reduce
6 7.00M $226.03M 3.77%
3.77%
Add
7 3.51M $199.89M 3.34%
3.34%
Reduce
8 4.50M $182.34M 3.04%
3.04%
Add
9 21.94M $168.28M 2.81%
2.81%
Add
10 300.04K $162.59M 2.71%
2.71%
Add
11 5.00M $156.35M 2.61%
2.61%
Add
12 1.10M $154.72M 2.58%
2.58%
Reduce
13 1.35M $154.09M 2.57%
2.57%
New
14 12.16M $151.29M 2.53%
2.53%
Hold
15 800.00K $147.51M 2.46%
2.46%
Add
16 6.00M $142.26M 2.38%
2.38%
Reduce
17 3.35M $128.68M 2.15%
2.15%
Hold
18 4.50M $112.28M 1.87%
1.87%
Add
19 4.08M $111.00M 1.85%
1.85%
Add
20 3.59M $110.65M 1.85%
1.85%
Hold
21 2.76M $98.46M 1.64%
1.64%
Reduce
22 8.11M $94.83M 1.58%
1.58%
Add
23 1.07M $89.10M 1.49%
1.49%
Reduce
24 1.20M $86.76M 1.45%
1.45%
Add
25 1.00M $81.90M 1.37%
1.37%
New
26 2.50M $80.05M 1.34%
1.34%
Add
27 3.33M $78.27M 1.31%
1.31%
Hold
28 4.10M $76.30M 1.27%
1.27%
Hold
29 4.41M $73.62M 1.23%
1.23%
New
30 2.13M $68.89M 1.15%
1.15%
Reduce
31 3.83M $64.34M 1.07%
1.07%
Add
32 885.88K $58.29M 0.97%
0.97%
New
33 3.61M $55.34M 0.92%
0.92%
Hold
34 7.47M $55.20M 0.92%
0.92%
Add
35 19.25M $55.05M 0.92%
0.92%
Hold
36 3.21M $54.97M 0.92%
0.92%
New
37 500.00K $53.22M 0.89%
0.89%
New
38 9.35M $49.15M 0.82%
0.82%
Hold
39 6.27M $48.31M 0.81%
0.81%
Hold
40 1.15M $46.64M 0.78%
0.78%
New
41 5.74M $46.21M 0.77%
0.77%
Hold
42 1.00M $38.06M 0.64%
0.64%
Reduce
43 2.51M $37.66M 0.63%
0.63%
Add
44 640.00K $37.52M 0.63%
0.63%
Reduce
45 500.00K $36.33M 0.61%
0.61%
New
46 1.07M $32.93M 0.55%
0.55%
Add
47 2.49M $28.71M 0.48%
0.48%
Hold
48 200.00K $28.37M 0.47%
0.47%
New
49 3.57M $25.78M 0.43%
0.43%
Hold
50 3.71M $25.28M 0.42%
0.42%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 60% R 60% F1 60% (modelled on 2026-Q1; 6/10 hit)

Low-confidence forecast This fund replaces about 32% of its Top-10 each quarter and backtests at F1 69% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 69% · recall 69% · F1 69% · avg rank error 3.2 · Top-10 turnover 32%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 40% 40% 40% INSM · SWTX · GH · ITCI · ARGX · ALKS · PLRX · DVAX · VRDN · AXSM SWTX · AMGN · APGE · INSM · DYN · ALNY · GH · ARGX · NTLA · OCUL
2024-Q2 80% 80% 80% SWTX · AMGN · APGE · DYN · NTLA · GH · OCUL · INSM · ALNY · ARGX AMGN · ARGX · AXSM · DYN · SWTX · INSM · GH · DVAX · ALNY · NTLA
2024-Q3 70% 70% 70% AMGN · ARGX · AXSM · DYN · SWTX · GH · DVAX · INSM · NTLA · ITCI ARGX · DVAX · GH · APLS · IMVT · SWTX · DYN · ITCI · OCUL · NTLA
2024-Q4 70% 70% 70% ARGX · DVAX · APLS · IMVT · GH · ITCI · SWTX · DYN · OCUL · NTLA DVAX · GH · ITCI · IMVT · APLS · SWTX · CYTK · OCUL · VRDN · PLRX
2025-Q1 70% 70% 70% DVAX · GH · ITCI · IMVT · APLS · CYTK · SWTX · OCUL · VRDN · GPCR ITCI · GH · DVAX · IMVT · PTGX · IONS · AKRO · CYTK · APLS · OCUL
2025-Q2 80% 80% 80% ITCI · DVAX · GH · IMVT · PTGX · IONS · AKRO · CYTK · APLS · BBIO GH · IONS · PTGX · DVAX · INSM · AKRO · IMVT · OCUL · APLS · CYTK
2025-Q3 80% 80% 80% IONS · GH · PTGX · INSM · AKRO · DVAX · IMVT · OCUL · APLS · CYTK GH · IONS · CYTK · AKRO · APLS · TARS · IMVT · DVAX · OCUL · ETNB
2025-Q4 60% 60% 60% GH · CYTK · IONS · TARS · AKRO · APLS · IMVT · DVAX · ETNB · OCUL XBI · IMVT · GH · GPCR · TARS · DVAX · CYTK · AXSM · APLS · PCVX
2026-Q1 80% 80% 80% XBI · IMVT · GPCR · GH · TARS · DVAX · AXSM · CYTK · PCVX · APLS XBI · GH · IMVT · TARS · PCVX · GPCR · AXSM · APLS · OCUL · VERA
2026-Q2 ★ 60% 60% 60% XBI · GH · IMVT · PCVX · TARS · GPCR · AXSM · OCUL · VERA · APLS GH · IMVT · GPCR · PCVX · ALNY · MANE · TARS · NUVL · ALKS · OCUL

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-13. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-13 Trading days32 Holdings13 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.

Portfolio return-7.91%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+5.81%vs benchmark
Barra annualised vol39.7%Model estimate
Realised vol45.7%Annualised in window
Weighted beta1.20Raw exposure
Factor / specific risk56% / 44%Share of variance
Top-10 concentration95.1%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2311-13Deep Track Capital, LPQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-7.91%Disclosed long book
QQQ synthetic benchmark-13.72%Liquidity-weighted constituents
Model universe, equal weight+0.30%Opportunity-cost reference
Excess return+5.81%Portfolio − benchmark
Arithmetic return sum-6.92%Difference vs compounded is the cross term
Weighted raw beta1.20Weighted holding betas
Realised volatility (annualised)45.72%Daily returns in window
Barra model volatility (annualised)39.68%Factor + specific
Factor share of variance56.5%Barra factors
Specific share of variance43.5%Stock residuals
Reported value$1.66B13F long US equity

2. Return attribution

The -6.92% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +2.26% 32.7%
Momentum & Growth 3 -3.07% -44.3%
Volatility & Tail Risk 7 -2.09% -30.2%
Industry 12 +7.54% 109.1%
Specific 1 -11.57% -167.2%
Return attribution (style + industry, %)-14.5-7.3+0.0+7.3+14.5Turnover+0.72Amihud Illiquidity-0.73Growth+0.76Non-linear Size+1.50Mid Cap-1.58Max Drawdown+1.62Beta+1.69Size+2.27Momentum-3.44Skewness-4.14Kurtosis+5.82Residual Volatility+5.84Health Care+7.72Historical Volatility-13.47
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.95 +8.12% +7.72% 111.7%
Residual Volatility Style +2.20 +2.66% +5.84% 84.5%
Kurtosis Style +0.83 +6.97% +5.82% 84.2%
Size Style -1.24 -1.83% +2.27% 32.8%
Beta Style +0.35 +4.85% +1.69% 24.5%
Max Drawdown Style -0.83 -1.96% +1.62% 23.4%
Non-linear Size Style +1.64 +0.91% +1.50% 21.7%
Growth Style +0.48 +1.57% +0.76% 10.9%
Turnover Style -0.15 -4.77% +0.72% 10.5%
Leverage (Downside Vol) Style -0.30 -1.82% +0.54% 7.8%
Liquidity Style +0.33 +0.22% +0.07% 1.0%
Information Technology Industry +0.05 -3.57% -0.18% -2.5%
Short-term Reversal Style -0.48 +0.79% -0.38% -5.5%
Amihud Illiquidity Style +1.80 -0.40% -0.73% -10.5%
Mid Cap Style +0.93 -1.69% -1.58% -22.8%
Momentum Style +1.03 -3.34% -3.44% -49.8%
Skewness Style +0.98 -4.21% -4.14% -59.8%
Specific Specific — — -11.57% -167.2%
Historical Volatility Style +1.05 -12.86% -13.47% -194.8%

3. Risk attribution

Annualised volatility is 39.68%; factor risk explains 56.5% of variance and specific risk 43.5%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-46.9-23.5+0.0+23.5+46.9Information Technology+0.76Short-term Reversal+0.82Non-linear Size+1.57Skewness+2.09Beta+2.47Max Drawdown+2.51Mid Cap+2.65Amihud Illiquidity+2.79Size+3.10Momentum+5.17Residual Volatility+7.98Historical Volatility+8.85Health Care+15.33Specific+43.46
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 43.5% +17.25% 17.2%
Health Care Industry +0.95 15.3% +6.08% 6.1%
Historical Volatility Style +1.05 8.8% +3.51% 3.5%
Residual Volatility Style +2.20 8.0% +3.17% 3.2%
Momentum Style +1.03 5.2% +2.05% 2.0%
Size Style -1.24 3.1% +1.23% 1.2%
Amihud Illiquidity Style +1.80 2.8% +1.11% 1.1%
Mid Cap Style +0.93 2.6% +1.05% 1.1%
Max Drawdown Style -0.83 2.5% +0.99% 1.0%
Beta Style +0.35 2.5% +0.98% 1.0%
Skewness Style +0.98 2.1% +0.83% 0.8%
Non-linear Size Style +1.64 1.6% +0.62% 0.6%
Short-term Reversal Style -0.48 0.8% +0.32% 0.3%
Information Technology Industry +0.05 0.8% +0.30% 0.3%
Growth Style +0.48 0.5% +0.20% 0.2%
Liquidity Style +0.33 0.4% +0.15% 0.1%
Leverage (Downside Vol) Style -0.30 -0.5% -0.18% -0.2%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.6-0.60.51.52.5Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.24 +2.10 -3.34
Non-linear Size +1.64 +1.68 -0.04
Mid Cap +0.93 +0.13 +0.81
Beta +0.35 +1.29 -0.95
Momentum +1.03 +0.72 +0.32
Short-term Reversal -0.48 -0.64 +0.16
Residual Volatility +2.20 -0.40 +2.60
Historical Volatility +1.05 +0.86 +0.19
Liquidity +0.33 +0.11 +0.22
Amihud Illiquidity +1.80 +1.16 +0.64
Turnover -0.15 +0.21 -0.36
Growth +0.48 +0.58 -0.10
Leverage (Downside Vol) -0.30 +0.14 -0.44
Skewness +0.98 +0.24 +0.74
Kurtosis +0.83 +0.21 +0.62
Max Drawdown -0.83 -0.08 -0.74

5. Industry allocation & Brinson

Industry allocation (weight, %)-9.519.047.576.1104.6Communication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsInformation TechnologyHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 4.9% 73.6% -12.58% -19.18% +4.03% +4.86% -4.54% +13.50%
Communication Services 0.0% 2.6% +0.00% -15.54% +0.06% +0.41% -0.41% +0.41%
Utilities 0.0% 0.8% +0.00% +11.58% -0.20% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.58% -0.24% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +5.56% -1.66% -0.49% +0.49% -0.49%
Industrials 0.0% 11.1% +0.00% +7.16% -2.27% -0.80% +0.80% -0.80%
Health Care 95.1% 1.7% -7.77% +9.16% +20.97% -0.29% -15.81% -7.55%
Total +20.59% +3.43% -19.20% +4.82%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
GH GUARDANT HEALTH INC Health Care 30.14% -14.95% -4.51% Reduce
UTHR UNITED THERAPEUTICS CORP DEL Health Care 9.79% +9.09% +0.89% Add
GPCR STRUCTURE THERAPEUTICS INC Health Care 9.42% -36.04% -3.39% Add
GRAL GRAIL INC Health Care 9.32% -17.29% -1.61% Reduce
INSM INSMED INC Health Care 9.28% +6.15% +0.57% New
TNGX TANGO THERAPEUTICS INC Health Care 6.76% +2.20% +0.15% Add
MAZE MAZE THERAPEUTICS INC Health Care 6.69% +26.31% +1.76% Add
WGS GENEDX HOLDINGS CORP Health Care 5.23% -27.57% -1.44% Add
TEM TEMPUS AI INC Information Technology 4.93% -12.58% -0.62% New
BBIO BRIDGEBIO PHARMA INC Health Care 3.51% +19.00% +0.67% New
GENB GENERATE BIOMEDICINES INC Health Care 2.27% -19.64% -0.45% Add
BEAM BEAM THERAPEUTICS INC Health Care 1.47% -6.63% -0.10% Hold
MNKD MANNKIND CORP Health Care 1.18% +5.90% +0.07% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 MAZE Health Care 6.69% +26.31% +1.76%
2 UTHR Health Care 9.79% +9.09% +0.89%
3 BBIO Health Care 3.51% +19.00% +0.67%
4 INSM Health Care 9.28% +6.15% +0.57%
5 TNGX Health Care 6.76% +2.20% +0.15%
6 MNKD Health Care 1.18% +5.90% +0.07%
7 BEAM Health Care 1.47% -6.63% -0.10%
8 GENB Health Care 2.27% -19.64% -0.45%
9 TEM Information Technology 4.93% -12.58% -0.62%
10 WGS Health Care 5.23% -27.57% -1.44%
11 GRAL Health Care 9.32% -17.29% -1.61%
12 GPCR Health Care 9.42% -36.04% -3.39%
13 GH Health Care 30.14% -14.95% -4.51%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned -7.91%, versus -13.72% for the QQQ synthetic benchmark — an excess of +5.81%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +7.72%, Residual Volatility +5.84%, Kurtosis +5.82%; the largest drags came from Historical Volatility -13.47%, Skewness -4.14%, Momentum -3.44%. Specific (stock-level) return contributed -11.57%.
  3. Risk attribution: Barra model volatility is 39.68% annualised; factor risk explains 57% of variance and specific risk 43%. The largest factor risk sources are Health Care 15.3%, Historical Volatility 8.8%, Residual Volatility 8.0%.
  4. Style tilt: size -1.24, momentum +1.03, volatility +1.05, liquidity +0.33; the weighted raw beta is 1.20. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+93.3 pp), the largest underweight is Information Technology (-68.7 pp). Allocation contributed +20.59%, selection +3.43% and interaction -19.20%.
  6. Concentration: the top-10 positions are 95.1% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Deep Track Capital, LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Deep Track Capital, LP reported 72 equity positions worth $5.99B in aggregate; its largest disclosed positions were GH ($500.42M), BMRN ($382.46M), IMVT ($309.45M).

How large is Deep Track Capital, LP's portfolio?

Deep Track Capital, LP reported $5.99B of long equity holdings across 72 positions as of 2026-Q3. Top-10 holdings account for 44.4% of reported value.

What is Deep Track Capital, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deep-track-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →